Andrew T. Wilkins, Ph.D.

Dr. Andrew Wilkins is a patent attorney with a focus on biotechnology. He has extensive experience with worldwide patent portfolio development and life cycle management, non-infringement and invalidity analysis, post-grant proceedings and IP due diligence for companies and investors in the biotechnology industry. Areas of experience include:

  • Therapeutic antibodies and antibody-like molecules for oncology, autoimmune, cardiovascular and infectious disease indications
  • Immunotherapy, including CAR and recombinant TCR technologies, peptide-based vaccines and immune checkpoint antibodies
  • Antibody and TCR discovery and engineering technologies
  • Glycoengineering technologies, including antibody Fc glycoengineering technologies
  • Viral delivery technologies, including lentiviral and AAV delivery technologies
  • Gene therapy technologies, including gene replacement and gene editing technologies
  • CMC manufacturing technologies for therapeutic proteins (e.g, antibodies), including protein purification, QC analysis and formulation
  • Biocompatible drug delivery vehicles, including controlled release nanoparticle liposome technologies
  • Drug screening assays
  • RNAi technologies
  • Bayh-Dole compliance in acquisition or licensing of IP based upon NIH-funded research

Andrew has extensive academic and industrial research experience, including as: an Instructor in Medicine at Harvard Medical School/Beth Israel Deaconess Medical Center in Boston; a graduate research student with GlaxoSmithKline, UK; a postdoctoral research associate with MRC Laboratory of Molecular Biology, UK; and an undergraduate research student with Celltech PLC, UK. 

Court Memberships

  • Massachusetts
  • U.S. Patent and Trademark Office 


  • Selected for Massachusetts Super Lawyers "Rising Stars," 2016-2020
  • Suffolk Law School Best First Year Oral Advocate Award
  • Charles A. King Trust Postdoctoral Fellowship
  • Wellcome Trust International Prize Postdoctoral Research Fellowship


  • Author/co-author of 12 scientific articles and reviews in internationally recognized, peer-reviewed journals including: Genes and Development, Current Biology, Biochemical Journal, Genome Biology, Cell Motility and the Cytoskeleton, Trends in Genetics, and Methods in Enzymology.  

Photo of Andrew T. Wilkins, Ph.D.
  • Boston

    28 State Street
    Suite 700
    Boston, MA 02109
F: 857.300.4001


Michael Saraiva


Suffolk University Law School,

University of London, U.K.,
Ph.D., Molecular Cell Biology

University of Glasgow, U.K.,
B.Sc., Biochemistry